Physician profile
Timothy Reed
NPI 1457320632
$1,348.64
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,065 · 2020: $273 · 2024: $11.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.86 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $253.28 | 2019-2020 | |
| Pfizer INC. | $216.54 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $147.18 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $142.02 | 2019 | |
| Novo Nordisk INC | $107.28 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.80 | 2019 | |
| Glaxosmithkline, LLC. | $59.88 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $21.42 | 2019 | |
| Astellas Pharma US INC | $20.89 | 2019 | |
| Amarin Pharma, INC. | $18.19 | 2020 | |
| My01 INC. | $11.30 | 2024 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.